Lysosomal enzymes in preterm infants with bronchopulmonary dysplasia: A potential diagnostic marker

Clinica Chimica Acta

Volumn 278, Issue 1, 1998, Pages 23-34

  Goi, Giancarlo ^a   Bairati, Chiara ^a   Massaccesi, Luca ^a   Lombardo, Adriana ^a   Bonafè, Luisa ^b   Zanardo, Vincenzo ^b   Burlina, Alberto ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Bronchopulmonary dysplasia; Dexamethasone therapy; Diagnostic marker; Lysosomal enzymes; N Acetyl d glucosaminidase isoenzymes; Preterm infants

Indexed keywords

DEXAMETHASONE; LYSOSOME ENZYME; MARKER; N ACETYL BETA GLUCOSAMINIDASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; ENZYME ACTIVITY; FEMALE; HUMAN; LUNG DYSPLASIA; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; DEXAMETHASONE; GLYCOSIDE HYDROLASES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LYSOSOMES;

EID: 0031758822     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00129-6     Document Type: Article

References (36)

1. Northway Jr. WH, Rosan RC, Porter DJ. Pulmonary disease following sequelae of bronchopulmonary dysplasia. N Engl J Med 1967;276:357-68.
2. Northway Jr. WH. Bronchopulmonary dysplasia: then and now. Arch Dis Child 1990;65:1076-81.
3. Bancalari E. Pathogenesis of bronchopulmonary dysplasia: an overview. In: Bancalari E, Stocker JT, editors. Bronchopulmonary dysplasia. Washington, DC: Hemisphere, 1988, p. 3-15.
4. Cherukupalli K, Larson JE, Rotschild A, Thurlbeck WM. Biochemical, clinical and morphologic studies on lungs of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996;22:215-9.
5. Thurlbeck WM. Prematurity and the developing lung. In: Holtzman RB, Frank L, editors. Clinics in perinatology, vol. 19, Philadelphia: W.B. Saunders Company, 1992, p. 497-520.
6. Heath MF, Jacobson W. Developmental changes in enzyme activities in fetal and neonatal rabbit lung. Cytidyltransferase, cholinephosphotransferase, phospholipase A1 and A2, β-galactosidase and β-glucuronidase. Pediatr Res 1984;18:395-401.
7. Simeoni U, Schinzler B, Massfelder T, et al. Specific developmental profiles of lysosomal and brush border enzymuria in the human. Biol Neonate 1994;65:1-6.
8. Shattuck KE, Richardson CJ, Rassin DK, Lobe TE. Development of serum hexosaminidase activity in infants. Biol of Neonates 1986;49:126-31.
9. Lobe TE, Richardson CJ, Rassin DK, Mills R, Schwartz MZ. Hexosaminidase: a biochemical marker for necrotizing enterocolitis in the preterm infants. Am J Surg 1984;147:49-52.
10. Rajashree S, Puvanakrishnan R. Alterations in certain lysosomal glycohydrolases and cathepsin in rats on dexamethasone administration. Mol cell Biochem 1996;154:165-70.
11. Hicks JJ, Duran-Reyes G, Diaz-Flores M. Effect of dexamethasone as an inhibitor of implantation and embryo development in rat; lysosomal role. Contraception 1994;50:581-9.
12. Shepherd VL, Konish MG, Stahl P. Dexamethasone increases expression of mannose receptors and decreases extracellular lysosomal enzyme accumulation in macrophages. J Biol Chem 1985;260:160-4.
13. Calvo P, Barba JL, Cabezas JA. Serum β-glucuronidase, β-glucosidase, α-fucosidase, α-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer. Clin Chim Acta 1982;11:15-9.
14. Goi G, Fabi A, Lorenzi R, et al. Serum enzymes of lysosomal origin as indicators of metabolic control in diabetes: comparison with glycated hemoglobin and albumin. Acta Diabetol Lat 1986;23:117-25.
15. Lombardo A, Goi G, Pistolesi E, et al. Behaviour of several enzymes of lysosomal origin in human plasma during pregnancy. Clin Chim Acta 1984;143:253-64.
16. Corral J, Miralles JM, Garcia-Pascual IJ, et al. Increased serum N-acetyl-β-D-glucosaminidase and α-D-mannosidase activities in obese subjects. Clin Invest 1992;70:880-4.
17. Karkkainen P, Poikolainen K, Salaspuro M. Serum β-hexosaminidase as a marker of heavy drinking. Alcohol Clin Exp Res 1990;14:187-90.
18. Goi G, Burlina AB, Moreschi C, et al. Enzymes of lysosomal origin in the serum of infants of diabetic mothers. Behaviour in the first days after birth. Acta Diabetol Lat 1988;25:351-60.
19. Goi G, Burlina AB, Bairati C, Bordugo A, Zanardo V, Zacchello F. Enzymes of lysosomal origin in plasma of twin neonates. Clin Chim Acta 1993;214:61-71.
20. Lombardo A, Caimi L, Marchesini S, Goi G, Tettamanti G. Enzymes of lysosomal origin in human plasma and serum; assay conditions and parameters influencing the assay. Clin Chim Acta 1980;108:337-46.
21. Goi G, Besozzi M, Bairati C, et al. Assay of enzymes of lysosomal origin in plasma. I. Preparation of a stable liquid material for calibration and quality control for lysosomal enzymes in plasma. Eur J Clin Chem Clin Biochem 1992;30:595-8.
22. Goi G, Bairati C, Roggi C, et al. The lysosomal N-acetyl-β-D-glucosaminidase (NAG) isoenzymes in plasma: study of distribution in a general population by a simple routine chromatofocusing procedure. Clin Chim Acta 1993;221:47-57.
23. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk from bronchopulmonary dysplasia. N Engl J Med 1989;320:1505-10.
24. Bronchopulmonary dysplasia. In: Guidelines for the care of children with chronic lung disease. Bureau of maternal and child health and resource development. Pediatr. Pulmonol 1989;6(Suppl. 3):3-4.
25. Snedecor GW, Cochram WG. Statistical methods, Ames: Iowa State University Press, 1967.
26. Norusis MJ. SPSS/pc + SPSS Inc., Chicago, USA, 1986.
27. Hall GH. The clinical application of Bayes Theorem. The Lancet 1967;Sept:555-557.
28. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dyaplasia develops. Pediatrics 1996;97(2):210-5.
29. Oron U. Proteolytic enzyme activity in rat hindlimb muscles in fetus and during post-natal development. Int J Dev Biol 1990;34:457-60.
30. Glew RH, Basu A, Prence EM, Remaly AT. Lysosomal storage diseases. Lab Invest 1985;53:250-69.
31. Burlina AB, Goi G, Fabi A, Lombardo A, Gaburro D, Tettamanti G. Behaviour of some lysosomal enzymes in the plasma of insulin-dependent diabetic patients during artificial pancreas treatment. Clin Biochem 1987;20:423-7.
32. Allen JM. Lysosomes in bacterial infection. In: Dingle JT, Fell HB, editors. Lysosomes in biology and pathology. Amsterdam-London Publishing Company, 1975, p. 41-64.
33. Henson PM. Secretion of lysosomal enzymes induced by immune complexes and complement. In: Dingle JT, Fell HB, editors. Lysosomes in biology and pathology. Amsterdam-London Publishing Company, 1976, p. 99-126.
34. Rush MG, Hazinski A. Current therapy of bronchopulmonary dysplasia. In: Bancalari E, Stocker JT, editors. Bronchopulmonary dysplasia. Washington, DC: Hemisphere 1988, p. 563-90.
35. Mammel MC, Green TP, Johnson DE, Tompson TR. A controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1983;1(8338):1356-8.
36. Ackerman NR, Beebe JR. Effects of pharmacologic agents on release of lysosomal enzymes from alveolar mononuclear cells. J Pharm Exp Ther 1975;193:603-13.